CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
出版年份 2016 全文链接
标题
CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways
作者
关键词
Glioma, CRM1 inhibitor, S109, Proliferation, Cell cycle
出版物
Journal of Hematology & Oncology
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-10-12
DOI
10.1186/s13045-016-0338-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune phenotypes predict survival in patients with glioblastoma multiforme
- (2016) Haouraa Mostafa et al. Journal of Hematology & Oncology
- Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells
- (2015) Mingshan Niu et al. CANCER BIOLOGY & THERAPY
- NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells
- (2015) Zhiyun Yu et al. CANCER LETTERS
- Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity
- (2015) Mingshan Niu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- TMEM140 is associated with the prognosis of glioma by promoting cell viability and invasion
- (2015) Bin Li et al. Journal of Hematology & Oncology
- Hugl-1 inhibits glioma cell growth in intracranial model
- (2015) Xuejiao Liu et al. JOURNAL OF NEURO-ONCOLOGY
- Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression
- (2015) Mingshan Niu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein
- (2015) Jo Ishizawa et al. PHARMACOLOGY & THERAPEUTICS
- Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
- (2015) Marc Zuckermann et al. Nature Communications
- Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer
- (2015) Xuejiao Liu et al. Journal of Ovarian Research
- RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy
- (2015) Paola Indovina et al. Oncotarget
- Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
- (2015) Michelandrea De Cesare et al. Oncotarget
- Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer
- (2015) Jiankun Gao et al. Oncotarget
- Nuclear Trafficking in Health and Disease
- (2014) Amir Mor et al. CURRENT OPINION IN CELL BIOLOGY
- XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
- (2014) Giovanni Gravina et al. Journal of Hematology & Oncology
- Nucleo-cytoplasmic transport as a therapeutic target of cancer
- (2014) Giovanni Luca Gravina et al. Journal of Hematology & Oncology
- Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- (2014) Kaushal Parikh et al. Journal of Hematology & Oncology
- Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastoma
- (2014) Adam L. Green et al. NEURO-ONCOLOGY
- Atomic basis of CRM1-cargo recognition, release and inhibition
- (2014) Ho Yee Joyce Fung et al. SEMINARS IN CANCER BIOLOGY
- High Cytoplasmic FOXO1 and pFOXO1 Expression in Astrocytomas Are Associated with Worse Surgical Outcome
- (2013) Chao Chen et al. PLoS One
- Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1
- (2013) Qingxiang Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
- (2012) Jian Chen et al. CELL
- Current clinical development of PI3K pathway inhibitors in glioblastoma
- (2012) P. Y. Wen et al. NEURO-ONCOLOGY
- Cooperativity within and among Pten, p53, and Rb Pathways Induces High-Grade Astrocytoma in Adult Brain
- (2011) Lionel M.L. Chow et al. CANCER CELL
- FOXO1: A Potential Target for Human Diseases
- (2011) Huarui Lu et al. CURRENT DRUG TARGETS
- Differential Response of Glioma Cells to FOXO1-Directed Therapy
- (2009) Cara J. Lau et al. CANCER RESEARCH
- EXPRESSION OF CRM1 IN HUMAN GLIOMAS AND ITS SIGNIFICANCE IN P27 EXPRESSION AND CLINICAL PROGNOSIS
- (2009) Aiguo Shen et al. NEUROSURGERY
- Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments
- (2008) A. A. Brandes et al. CLINICAL CANCER RESEARCH
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now